ISHP 2020 Fall Meeting

2020 Fall Virtual Poster Session



Poster Title: Creation of a population health diabetes registry

Poster Authors: Katie Erickson, PharmD, BCPS, BCACP and Nydia Lovell

Abstract: Disease registries use data to identify a cohort of patients who may need medical interventions and are used by organizations strong in population health. The private sector has faced many challenges in creating registries due to the complexities of how data is gathered and the variety of care settings in which patients obtain services. This project outlines the process for identifying sources and gathering of data to create a diabetes registry. This registry contains data from insurance claims which captures information when a patient seeks care across multiple locations. Pharmacists can use this type of registry to identify and provide interventions to diabetics who have had frequent diabetes related emergency department visits, have abnormal labs, have concomitant diseases such as chronic kidney disease, are missing a statin, and more. The creation of a diabetes registry provides the opportunity and data needed for pharmacists to deliver proactive high-quality pharmaceutical care.


Poster Title: Idaho pharmacists' perceptions of the expanded pharmacy practice laws, implications for the profession

Poster Authors: Richard Johns

Abstract: This study set out to explore pharmacists’ perceptions regarding expanded pharmacy practice laws in Idaho and the possible implications of those laws on the practice of pharmacy. An anonymous IRB approved qualtrics survey was sent to all practicing pharmacists within the State of Idaho. Survey questions were developed to determine pharmacist perceptions regarding expanded pharmacy practice laws as well as current views in regard to workflow and evaluation of prescriptive authority. Data will be analyzed based on participants’ age, gender, specific area of practice, year of graduation, geographical location of practice within Idaho, involvement in professional organizations, and whether or not the participant completed a pharmacy residency. These data will be useful to evaluate the practical application of changes in the law governing pharmacy practice from the perspective of current practitioners. 

Poster Title: Development of a novel interprofessional program to improve mental healthcare access in Idaho

Poster Authors: G. Lucy Wilkening, PharmD; Ryan Manwaring, DNP, APRN, PMHNP-BC; and Eric Silk, PhD

Abstract:  In 2017, Idaho had the fifth highest rate of suicide in the nation, and currently ranks forty-ninth nationally in mental healthcare access. In response to these statistics and in an effort to improve mental healthcare reach, our institution now offers an interprofessional program that provides licensed psychologists with training in the use of psychotropic medications. This report aims to describe our experience creating this novel educational program within a college of pharmacy, the expanding role of pharmacists in combatting statewide mental healthcare crises through clinical education, and the anticipated future collaborative dynamics of pharmacists and prescribing clinical psychologists. We also describe our plans for development and implementation of an on-site outpatient mental health clinic, and the provision of medication treatment through collaborations between a psychiatric pharmacist, psychiatric nurse practitioner, and prescribing psychologists in-training.


Poster Title: Evaluation of prescribing practices of long-acting injectable antipsychotics

Poster Authors: Samichhya Baruwal, PharmD; Shelby White, PharmD, BCPS, BCPP; Josh Gerving, PharmD, BCPS, BCPP

Abstract: Long-acting injectable (LAI) antipsychotics can be effective treatment options in patients who relapse due to non-adherence. LAI antipsychotics carry the potential for error with regards to dosing, titration, and administration. While the pharmacists at our institution perform an initial evaluation of the medication to assess appropriateness, pharmacists do not conduct a review on the continued use of these agents. This retrospective medication use evaluation aims to evaluate the prescribing practices of long-acting injectable antipsychotics at our medical institution. This project has the potential to shed light on the importance of pharmacist interventions in dosing and administration of LAI antipsychotics. Patients will be included if they are at least 18 years of age and have an active LAI antipsychotic prescription within the last 120 days. This project did not require an IRB approval as it is an internal quality improvement project.

Poster Title: Alteplase replacement program evaluation

Poster Authors: Emily Bush, PharmD

Abstract: Close monitoring of alteplase is important to ensure safe, appropriate, and cost-effective use. The product return and replacement offered by Genentech is beneficial to offset high costs for medication wasted. The purpose of the review is to examine replacement program practices and assess cost-saving opportunities. This project meets criteria for and was approved by IRB as a performance improvement project and not research involving human subjects. A retrospective chart review was conducted from January 2019 to September 2020 for acute ischemic stroke patients presenting to the emergency department to compare how frequently we are wasting alteplase vials versus getting replacement product through Genentech. Since initiation, alteplase replacement programs have been used 70% of the time. The replacement program through Genentech has decreased the lost revenue associated with alteplase waste by 77%. Moving forward, we will increase utilization of reimbursement opportunities to further minimize the cost burden of alteplase.

Poster Title: Evaluation of hypertension management interventions identified by an electronic dashboard tool

Poster Authors: Kristin Cleverdon, PharmD; Paul Black, PharmD, BCPS; Patrick Spoutz, PharmD, BCPS; Jen Diaz, PharmD

Abstract: SAIL performance measures have demonstrated that our medical institution is not meeting the national target for hypertension management. In response to this issue, an electronic dashboard was created to identify patients who could benefit from a clinician evaluating and assisting with blood pressure control. This prospective medication use evaluation (MUE) seeks to assess the effectiveness of nursing and pharmacist interventions made in response to the Hypertension Management Dashboard initiated in July 2020. IRB was not required as it is an internal quality improvement project. The MUE will ultimately look at the type of intervention made by clinicians, the result of the intervention (ie medication initiated), the change in blood pressure before and after an intervention, and the SAIL ihd53h_ec measure in FY20 Q2 vs. FY21 Q2. Patients will be included if they are reviewed by staff in response to dashboard inclusion anytime between July 2020 and April 2021.

Poster Title: Assessment of intraveneous immune globulin and body weight dosing

Poster Authors: Brittany Galop, PharmD, MS; Dallin Poulsen, PharmD MBA/HSA; and Mel Sater, PharmD

Abstract: Intravenous immune globulin (IVIG) requires weight-based dosing with guidelines supporting actual body weight (ABW). The purpose of this study is to determine whether switching IVIG dosing from ABW to IBW reduces cost. This retrospective study is a medication utilization evaluation that includes patients 18 years and older who received an IVIG dose from January 1 to December 31, 2019. This project meets criteria for and was approved by IRB as a performance improvement project (PI) and not research involving human subjects. 197 patients received at least one dose with 56.4% (711) of IVIG being dosed off of ABW while 43.6% (550) received IBW dosing. The utilization of IBW dosing reduced cost by approximately $930,000 for the 2019 fiscal year. Moving forward, we look to utilize this data to standardize IBW dosing for all new IVIG initiations at our health system’s facilities.

Poster Title: Rational Use of Rasburicase

Poster Authors: Maria Herbison, PharmD and Yvonne Hewett, PharmD

Abstract:  The purpose of this project was to assess current dosing practices and identify potential cost savings of rasburicase for tumor lysis syndrome in the adult oncology population. A retrospective chart review was conducted from January 1, 2019 - July 31, 2020. Thirty-seven oncology patients were identified and all received rasburicase using flat-based dosing, the most common initial dose being 7.5 mg. Only two patients required repeat dosing. The average cost of rasburicase for each patient was $8,097. In conclusion, utilizing one-time flat-based dosing of rasburicase is sufficient at treating hyperuricemia related to tumor lysis syndrome in most adult oncology patients. Further cost savings may be achieved in the future utilizing lower initial flat-based doses of rasburicase. This project meets criteria for and was approved by IRB as a performance improvement project and not research involving human subjects.

Poster Title: Evaluation of the safety and efficacy of vancomycin when dosed based on steady state trough

Poster Authors: Grayson Kendall, PharmD; Charles Jensen, PharmD; and Kristen Thomas, PharmD

Abstract:  In an effort to reduce vancomycin toxicities new dosing strategies are being implemented. We sought to establish a reference to compare new and traditional dosing outcomes. A retrospective chart review of all pediatric patients who had received at least 3.5 consecutive days of vancomycin was performed. This medication utilization evaluation was determined to be exempt from review by the Institutional Review Board as it was retrospective, no greater risk was imposed, and was classified as performance improvement. 30 patients met criteria (7 females, 23 males, aged 1 week to 14 years old). Two of these patients developed acute kidney injury, both with initial CrCl less than 30 mL/minute, one with a trough greater than 15 mcg/mL and one with additional nephrotoxic medications. This data will aid in assessing the appropriateness of AUC:MIC dosing and its impact on the rates of toxicity and resolution of infection in pediatric patients.

Poster Title: Utilizing Meds 2 Beds Pharmacists to Promote Safe Opioid Disposal

Poster Authors: Alexandria Schultz, Catherine Gundlach, Megan Turner

Abstract: With the recent revision of The Joint Commission standards, health systems are required to adequately address patient education regarding safe storage and disposal of opioids. Almost all orthopedic surgical patients receive opioid pain medications upon discharge and may not take the full amount prescribed as post-operative pain diminishes. Targeting this population, patients receiving opioids upon discharge using the Meds 2 Beds pharmacy discharge bedside delivery service will be provided a medication disposal pouch with counseling. A pharmacist will perform a follow-up phone call four to five weeks post discharge inquiring about the amount of pain medications used, disposal pouch use, and patient satisfaction of medication counseling. The information will be analyzed to identify potential areas of improvement for counseling, institutional discharge pain medication prescribing, and unused medication disposal rates. This project was approved by the institutional review board as a performance improvement project and not research involving human subjects.

Poster Title: Improving analgesia in burn patients: implementation of a subanesthetic ketamine protocol in a burn intensive care unit

Poster Authors: Rachel Proteau, PharmD; Lindsey Reeder; Erin Berry; and Eliza Borzadek

Abstract: Effective burn pain management is exceptionally complex, with prolonged and highly variable sources of pain throughout burn care. Opioids are a mainstay of therapy; however, effects of long term use are of significant concern. Ketamine at “subanesthetic” (i.e. analgesic) doses has gained popularity as an opioid sparing alternative across multiple pain settings. Among burn patients, ketamine is often cited for adjunct analgosedation, particularly during dressing changes. Analgesic applications of ketamine in unintubated patients represent a novel strategy for burn pain management at this institution. The primary objective of this project will be to determine whether implementation of a ketamine protocol significantly reduces cumulative morphine milligram equivalents (MME) required for pain management among unintubated burn patients in the burn intensive care unit. Data will be obtained via chart review and comparative statistics will be used for analysis. This project is Institutional Review Board (IRB) exempt as a quality improvement project.

Poster Title: Evaluating time to administration and average units given of prothrombin complex concentrate in fixed vs non-fixed dosing of warfarin reversal

Poster Authors: Tania Villaneuva-Sanchez, PharmD and Kathy Glem, PharmD, BCCP

Abstract:  Prothrombin complex concentrate (Kcentra) is an agent used in the reversal of anticoagulation in life-threatening bleeds and contains factors II, VII, IX, proteins C and S. The purpose of this MUE is to evaluate a newly implemented process of using fixed-dosed Kcentra in warfarin reversal. Data will be collected via retrospective chart review to compare the average time from order entry to administration, and the average number of units being given in fixed vs non-fixed dosing. This project is IRB exempt because it is a performance improvement project. Results are pending.

Poster Title: Implementation of a standardized venous thrombosis prophylaxis protocol at a community hospital

Poster Authors: Angela Cheung, PharmD; Brecon Powell; Eliza Borzadek; Erin Berry

Abstract:  Venous thromboembolism (VTE) is a major public health problem affecting 350,000 to 600,000 Americans annually. VTE is widely believed to be the most common preventable cause of hospital death. Appropriate thromboprophylaxis in high-risk medically ill patients has been shown to reduce risk of VTE by 30-65 percent, has a low incidence of major bleeding, and well-documented cost-effectiveness. VTE prophylaxis has been the Joint Commission’s National Patient Safety Goal since 2008. Despite the general availability of evidence-based best practices, institutions continue to struggle with implementation of standardized VTE prophylaxis protocols. The objective of this project is to assess the institutional adherence with an evidence-based VTE prophylaxis guidelines before and after implementation of a standardized protocol. Data collected will include patients’ demographic characteristics, body mass index, an assessment of risk of thrombosis and bleeding and will be collected via chart review utilizing electronic health records. This project is Institutional Review Board exempt.


Poster Title: Using social network analysis to identify facilitators

Poster Authors: Courtney Bonnema and Renee Robinson

Abstract: Many regions in Alaska are designated as Health Professional Shortage Areas. Patients in rural communities tend to have poorer access to healthcare and higher rates of diabetes. A social network analysis, quantifying relationships between providers, groups, and healthcare systems, was conducted. IRB approval obtained. Members of the Alaska Diabetes Coalition, a statewide initiative of healthcare providers and community partners, were surveyed to identify barriers to diabetes care and determine existing connections between patients, providers, and healthcare centers employed in their management. The top three reported barriers included; lack of insurance/inadequate insurance, lack of access/ability to pay for healthy foods, lack of patient engagement in diabetes self-care. Analysis of the network showed that tribal health sites have the greatest number of existing connections used to support diabetes management. It also demonstrated that community level partnerships do exist, but there are opportunities for sites to utilize resources closest to them.


Poster Title: Alaska assisted living home immunization program: A multidisciplinary, community health initiative for underserved populations in South Central Alaska

Poster Authors: Talethia Bogart, Jacob Jordan, Renee Robinson

Abstract:  Residents of assisted living homes (ALH) are especially susceptible to vaccine preventable illnesses, due largely to close quarters, typically being over the age of 65, and having more co-morbidities on average. The objectives of this program were 1) combat increased incidence of influenza, specifically among the high-risk, ALH population; 2) immunize all consenting ALH residents; 3) increase herd immunity through immunization of healthcare workers and resident family members; 4) expand program outreach; 5) provide student pharmacists the opportunity to learn and master skills needed for future practice. Seventeen teams, consisting of 66 volunteers, traveled across Southcentral Alaska, and administered 497 influenza vaccines in October, 2019. Continued recruitment efforts of community medical professionals, along with multidisciplinary student involvement, lays the foundation for ALH program sustainability and growth. Multidisciplinary medical teams provide volunteers and the public valuable exposure to skill sets of various medical providers, increasing public knowledge and interdisciplinary collaboration.

Poster Title: Understanding influenza vaccination rates, perceptions, and vaccine hesitancy in K-12 teachers and staff surveyed within the West Ada School District

Poster Authors: Dalys Davenport, PharmD Candidate; Elaine Nguyen, PharmD, MPH; Kevin Cleveland, PharmD, ANP; Kathy Eroschenko, PharmD

Abstract: Purpose: Misinformation and hesitancy contributes to decreased vaccination. Given the prominent role that teachers/staff serve in communities, we surveyed this population to understand influenza vaccination uptake, motivations, knowledge, and hesitancy.
Methods: An e-survey was distributed throughout the West Ada School District. Demographics, receipt of vaccine, influenza vaccination motivation, knowledge and reasons for hesitancy were collected. Surveys were distributed July 2020 and analyzed using descriptive statistics. This work was IRB-approved.
Results: A total of 504 surveys were completed. A majority of respondents (n=410;81%) received a yearly influenza vaccination. Reasons for vaccination included: avoidance of flu, reduction of spread, and prevention of complications. Reasons against vaccination included: lack of efficacy, side effects, and numerous “other” responses.
Conclusion: The majority of surveyed K-12 teachers/staff received their influenza vaccine last season. However, a small majority of teachers/staff are still hesitant due to misinformation regarding vaccinations.

Poster Title: Using National Survey Data: A Cross-Sectional Analysis of Surverys with Questions on Chronic Diseases and Social Determinants of Health

Poster Authors: Kathryn Fox, BA; Tayler Daniels'; Renee F. Robinson, PharmD, MPH, MSPharm; Elaine Nguyen, PharmD, MPH

Abstract: Introduction: Surveys are tools utilized by organizations and researchers to assess various populations. This project aimed to consolidate a list of national health surveys to make data source identification easier.
Methods: A cross-sectional analysis of current national survey data was conducted using the Office of the Assistant Secretary for Planning and Evaluation (ASPE) U.S. Department of Health and Human Services (DHHS) website(s). Surveys were assessed for inclusion criteria. Then, data on coverage of chronic diseases and social determinants of health (SDoH) were extracted from included surveys.
Results: A total of 39-data sources were identified. After screening, 16-surveys met inclusion criteria and were included in the extraction process.
Conclusion: This project identified 16-national health surveys containing questions related to chronic disease(s) and SDoH used to answer clinical, educational, and research questions. These national surveys cover a broad range of topics and can meet a variety of user needs.

Poster Title: Exploring barriers and facilitators to pharmacist-provided diabetes self-management education and support

Poster Authors: Gabriela Gawlik; Renee Robinson; Elaine Nguyen

Abstract: Purpose: Pharmacists are healthcare professionals with necessary clinical experience and knowledge to effectively manage and educate patients with diabetes and provide diabetes self-management education and support (DSMES) services. However, barriers exist to community pharmacists’ implementation of DSMES. The aim of the study is to explore pharmacists’ perspectives on DSMES, identify barriers and facilitators to pharmacist DSMES implementation, and guide program development to expand access to pharmacist-provided DSMES in Idaho.
Methods: A moderator guide was developed to guide six semi-structured interviews conducted with Idaho community pharmacists via Zoom between March-June 2020. Thematic, qualitative data analysis was conducted using HyperRESEARCH 4.5.1 software. Themes, patterns, and dominant concepts that emerged from respondents’ comments about DSMES and other clinical services delivered at community pharmacies in Idaho will be explored, labeled, and categorized into modifiable and nonmodifiable barriers and facilitators. This work was IRB-approved and consent obtained from all interview participants.

Poster Title: Cross-sectional analysis of commercially available mobile health applications for self-management of attention deficit hyperactivity disorder

Poster Authors: Kyle Logue; Courtney Bonnema; Annie Enderle; Renee Robinson

Abstract: Attention deficit hyperactivity disorder (ADHD) affects 10% of children in the United States. ADHD is primarily managed with medication and behavioral therapy. Many children with ADHD do not have access to these necessary treatments and additional support to manage their condition successfully. Mobile health applications (MHAs) have been used in other conditions to support self-management; however, it is unclear if commercially available ADHD MHAs support ADHD management. This study aims to identify and evaluate existing ADHD MHAs for ADHD self-management. A search for ADHD MHAs was completed in July 2020. The Mobile Application Rating Scale (MARS) was used to assess engagement, functionality, aesthetics, and information quality. To determine if the information provided was evidence-based, we use an adapted content assessment scale. Readability was assessed using Flesch-Kincaid Scale. Study deemed not research by Institutional Review Board.

Poster Title: Cross-sectional review of population health management studies with pharmacist involvement

Poster Authors: Radhika Narsinghani, PharmD Candidate 2021; Glenda Carr, PharmD; Amber Fisher, PharmD; Kathy Eroschenko, PharmD; Elaine Nguyen, PharmD, MPH

Abstract: Purpose: To systematically characterize studies with pharmacist involvement in population health management (PHM) by chronic diseases.
Methods: Literature on PHM was retrieved through a systematic search of MEDLINE and CINAHL Complete (from database inception-March 2018). Identified articles were reviewed for fulfillment of inclusion criteria. To be included, articles had to be outcomes of PHM, contain comparative data, include adults with chronic diseases, be available in English, and involve pharmacists in PHM. Next, included articles were reviewed and categorized by chronic diseases. 
Results: The systemic search retrieved 2,093 de-duplicated citations. After screening, 11 articles were included. PHM studies with pharmacist involvement covered the following chronic diseases: diabetes (n=5), cardiovascular disease (n=5), chronic kidney disease (n=1), and tobacco use (n=1). 
Conclusion: The majority of articles covered diabetes and cardiovascular disease. Further investigation on pharmacist involvement in PHM is needed, especially in regards to other diseases.

Poster Title: Associating PHQ-9 Scores and Food Insecurity

Poster Authors: Brittany Burch, Glenda Carr, PharmD

Abstract:  This study assessed whether an association between food insecurity and depression scores exist in participants presenting to a Community Health Screening (CHS) as approved by ISU Human Subject Committee. The Patient Health Questionnaire-9 (PHQ-9) and two validated food insecurity questions were reviewed from 138 participants (100 female, 38 male) who completed the CHS. PHQ-9 scores between 10-29 indicate moderate to severe depression and were considered a positive for this analysis. Using a Chi Square test, there was a statistically significant finding using a p-value <0.05 for each food insecurity question; worried about running out of food (p=0.0003) and running out of food (p=0.0134). Although there are many different factors that contribute to depression, food insecurity is to be considered to be one of them. Based on these findings from this population, food insecurity should be considered when diagnosing and treating depression.

Poster Title: Cross-sectional analysis of mobile health applications to support self-management of post-traumatic stress disorder

Poster Authors: Nana McMillan; Renee Robinson, PharmD, MPH, MSPharm

Abstract: Purpose: Mobile health apps can help increase access to care and provide strategies for post-traumatic stress disorder (PTSD) self-management. We sought to describe and compare consumer-driven mobile health apps available for PTSD self-management.

Methods: We conducted a cross-sectional analysis of commercially-available PTSD apps. We obtained readability scores for the apps that met our inclusion criteria using Flesch Kincaid, evaluated usability using the mobile application reading scale, and apps were assessed for resources, education, and tools for self-management. Study IRB Exempt.

Results: Our initial search yielded 199 apps, 16 apps specific to PTSD; however, 13 did not meet our inclusion criteria (consumer-directed, designed for PTSD management, English, no-cost). Only three apps provided treatment information, and only two were evidence-based. App readability scores ranged from grade 12 to 18.

Conclusion: Most currently available PTSD apps are not evidence-based, readable, and do not support self-management. Evidence-based, patient-guided, commercially-available PTSD apps are needed.

Poster Title: Mapping Idaho's community pharmacies and population density to evaluate accessibility

Poster Authors: James Parrish; Jose Lopez; Austin Pothikamjorn; Elaine Nguyen; and Renee Robinson,

Abstract: BACKGROUND: Pharmacists are the most accessible healthcare providers, capable of providing a wide range of healthcare services in the community setting. Our objective is to determine availability of community pharmacies in Idaho relative to geographic population density. This will highlight geographical areas and potential opportunities to fulfill community healthcare needs.

METHODS: Study data was collected from Idaho State Board Pharmacy website in July of 2020, and US population census data. A search was conducted to obtain a website-generated list of all active, licensed, community pharmacies with physical addresses. Data was collected into a spreadsheet for consolidation of information. ArcGIS software was then used to map community pharmacy and population data to identify potential geographical areas where pharmacies could better serve the community. This project utilizes publicly available data and is exempt from IRB review.


Poster Title: Mental health pharmacists: review of types of engagement and opportunities for collaborative partnership

Poster Authors: Mikayla Romney; Julia Boyle; and Renee Robinson

Abstract: Purpose: Describe mental health patient care, collaborative practice services provided by mental health pharmacists within a local medical center. Discuss potential for increased access to mental health services by incorporating pharmacists into the psychiatric treatment team and opportunities for pharmacists to address the persisting gap in mental health services.
Methods: We conducted a literature search and used qualitative case study methodologies to better understand services mental health pharmacists provide and associated programs.
Results: Pharmacists have shown that they are capable of expanding their role to more than the dispensing roles historically held. Opportunities for increased services by mental health pharmacists can lead to improved outcomes, timely patient care, and appropriate utilization of psychiatric medications.
Conclusions: Pharmacists work and collaborate with other healthcare providers in a variety of settings to provide mental health services. Pharmacists need to continue to expand their role in patient care, increasing access and improving health outcomes.

Poster Title: Cross-sectional study for opioid support applications: Identifying tools to support addiction self-management

Poster Authors: Carrie Urena and Renee Robinson

Abstract: Misuse of and addiction to opioids is a serious national crisis, affecting public health social and economic welfare. Healthcare and support resources available to help individuals struggling with substance use disorder (SUD) in rural communities are limited. The primary aim of this study is to describe and compare consumer-directed mHealth apps available to support addiction self-management efforts in individuals with SUD.  A multi-domain, 3-tier inclusion criterion was developed and used to identify relevant customer-focused apps on Google Play and Apple App Store, n=10. Few available mHealth apps were evidence-based, supported self-management, or provided necessary connections to available online and telehealth resources needed. In fact, no mHealth apps met all criteria; evidence-based, support self- management, or connect to necessary resources. More real time self-management supports are needed to overcome access barriers (e.g., transportation issues, provider shortages, and geographical constraints), and augment currently available mental health supports.


Poster Title: Perceived stress levels of students between different programs within the Kasiska Division of Health Sciences

Poster Authors: Megumi Harris; Madeline Foster; Brecon Powell, PharmD

Abstract: The purpose of this study was to assess the perceived stress levels between different programs with the Kasiska Division of Health Sciences. As well as, assessing if there is a difference between perceived stress levels brought on by COVID-19. IRB approval was exempt under category two. Students were emailed a survey link to Qualtrics and informed consent was in that email. There was no change between stress levels between different programs. However, there were changes between stress levels between different programs due to the transition with COVID-19. Programs that had a significant change in stress levels included: Counseling, Medical Lab Science, and Physical Therapy. Programs that had no significant change in stress levels included: Dental Hygiene, Pharmacy, Occupational Therapy, Physician Assistant. Due to the ongoing need for socially distanced and online learning environments, it may be beneficial for universities to consider increasing support for students.

Poster Title: Cross-sectional analysis of mobile health apps for self-management of depression or anxiety

Poster Authors: Radhika Narsinghani, PharmD; Renee Robinson, PharmD, MPH, MSPharm

Abstract: Purpose: Compare consumer-directed mobile-health applications (mHealth apps) available for self-management of depression and/or anxiety.
Methods: A systematic review of 93,849 consumer-apps was conducted using a 3-step inclusion-criteria. Step-one: available in English, downloadable, and aligned with established self-management program components. Step-two: defined depression/anxiety, described symptoms, and discussed greater than 2-management techniques. Step-three: screened for user-friendliness and self-management components (n=10). Apps were assessed for readability and validity.
Results: Seventy-percent of mHealth apps incorporated 4-major self-management components. Eighty-percent of apps described at least three DSM-5 symptoms. Thirty-three percent of apps were 5-grade-levels higher than general US comprehension estimates. Only 40% of reviewed apps provided evidence-based self-management support and only 20% were affiliated with an accredited organization.
Conclusion: mHealth apps have the potential to reduce barriers to access to mental health treatment. Further research is necessary to understand how pharmacists can better support patient self-management of depression/anxiety with mHealth apps.

Poster Title: Idaho pharmacists’ willingness and needs to provide COVID-19 services

Poster Authors: Tayler Daniels; Jeremy Boyle; Christopher Owens; and Renee Robinson

Abstract: Purpose: To determine Idaho pharmacists’ willingness to provide COVID-19 services, assess needed resources to provide services, and identify/prioritize other unmet community needs. 
Methods: We administered a survey to Idaho pharmacists with optional questions focused on pharmacist’s willingness to provide services, what resources and additional training they would need, assessing difficulty with 90-day prescriptions, and solicited additional feedback using an open-ended question. The survey was considered quality improvement and exempt from IRB approval.
Results: A total of 229 responses were received with approximately half from community settings. Most respondents (70%) were willing to provide COVID-19 testing. Adequate staffing, workflow changes, and the need for billing/reimbursement mechanisms were most frequently cited as barriers contributing to the COVID-19 response.
Conclusion: Our findings demonstrated most pharmacists are willing and able to contribute to the COVID-19 response. Removal of identified barriers will better allow Idaho pharmacists to engage in services.

Contact Us:
(208) 342-2581

P.O. Box 7625
Boise, ID 83707

Powered by Wild Apricot Membership Software